editorial | Q871232 |
scholarly article | Q13442814 |
P50 | author | Tsutomu Takeuchi | Q40949081 |
P2093 | author name string | Hideto Kameda | |
P2860 | cites work | Maraviroc, a chemokine receptor-5 antagonist, fails to demonstrate efficacy in the treatment of patients with rheumatoid arthritis in a randomized, double-blind placebo-controlled trial | Q36084912 |
Chemokine and chemokine receptor blockade in arthritis, a prototype of immune-mediated inflammatory diseases. | Q37943107 | ||
CCR5 blockade in rheumatoid arthritis: a randomised, double-blind, placebo-controlled clinical trial. | Q42943397 | ||
Preclinical and clinical investigation of a CCR5 antagonist, AZD5672, in patients with rheumatoid arthritis receiving methotrexate | Q42956746 | ||
Overcoming hurdles in developing successful drugs targeting chemokine receptors | Q46441158 | ||
Impaired macrophage function and enhanced T cell-dependent immune response in mice lacking CCR5, the mouse homologue of the major HIV-1 coreceptor | Q74477278 | ||
Why CCR2 and CCR5 blockade failed and why CCR1 blockade might still be effective in the treatment of rheumatoid arthritis | Q28742993 | ||
CC chemokine receptor 5 (CCR5) desensitization: cycling receptors accumulate in the trans-Golgi network | Q34438951 | ||
Baseline tumour necrosis factor alpha levels predict the necessity for dose escalation of infliximab therapy in patients with rheumatoid arthritis | Q35012157 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | rheumatoid arthritis | Q187255 |
P304 | page(s) | 114 | |
P577 | publication date | 2012-03-30 | |
P1433 | published in | Arthritis Research and Therapy | Q15757229 |
P1476 | title | What is the future of CCR5 antagonists in rheumatoid arthritis? | |
P478 | volume | 14 |
Q99408059 | C-C chemokine receptor type 5 links COVID-19, rheumatoid arthritis, and Hydroxychloroquine: in silico analysis |
Q50920198 | CCR5delta32 in systemic lupus erythematosus: implications for disease susceptibility and outcome in a Brazilian population. |
Q38172960 | Chemokine receptor modeling: an interdisciplinary approach to drug design |
Q90642824 | Role of Chemokines and Chemokine Receptors in Rheumatoid Arthritis |
Q47126167 | The HIV co-receptor CCR5 regulates osteoclast function. |
Q41945153 | The multiple chemokine-binding bovine herpesvirus 1 glycoprotein G (BHV1gG) inhibits polymorphonuclear cell but not monocyte migration into inflammatory sites. |
Q61443001 | The potential risks of C-C chemokine receptor 5-edited babies in bone development |
Search more.